First Time Loading...

JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 1.82 HKD -1.09% Market Closed
Updated: May 9, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.1B
-19%
Assets
Growth Rates:
1 Year
-23%
3 Years
-43%
5 Years
-
7 Years
-
10 Years
-
462.3m
-10%
Liabilities
Growth Rates:
1 Year
+6%
3 Years
+32%
5 Years
-
7 Years
-
10 Years
-
1.7B
-21%
Equity
Growth Rates:
1 Year
-28%
3 Years
-51%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
JW (Cayman) Therapeutics Co Ltd

2.1B
Assets
462.3m
Liabilities
2.1B
Assets
462.3m
Liabilities
Current Assets 1.1B
Cash & Short-Term Investments 1B
Receivables 16.9m
Other Current Assets 44.7m
Non-Current Assets 1.1B
PP&E 341.1m
Intangibles 711.2m
Other Non-Current Assets 26.3m
Current Liabilities 264.5m
Accounts Payable 109.1m
Other Current Liabilities 155.4m
Non-Current Liabilities 197.8m
Long-Term Debt 197.8m

Balance Sheet
JW (Cayman) Therapeutics Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
134
255
2 631
1 834
Cash
134
255
2 631
0
Cash Equivalents
0
0
0
1 834
Total Receivables
0
0
0
3
Inventory
1
3
3
39
Other Current Assets
37
4
14
19
Total Current Assets
171
261
2 647
1 895
PP&E Net
77
222
309
381
PP&E Gross
77
222
309
381
Accumulated Depreciation
5
22
46
53
Intangible Assets
80
157
775
816
Note Receivable
11
25
37
13
Other Long-Term Assets
2
4
11
11
Total Assets
341
N/A
669
+96%
3 779
+465%
3 117
-18%
Liabilities
Accounts Payable
0
0
1
3
Accrued Liabilities
26
29
56
88
Short-Term Debt
0
0
0
0
Current Portion of Long-Term Debt
43
10
11
20
Other Current Liabilities
156
83
170
88
Total Current Liabilities
225
123
237
199
Long-Term Debt
429
1 488
113
127
Total Liabilities
654
N/A
1 611
+146%
350
-78%
326
-7%
Equity
Common Stock
0
0
0
0
Retained Earnings
340
957
2 487
3 100
Additional Paid In Capital
41
41
6 023
6 081
Treasury Stock
0
0
0
0
Other Equity
14
26
106
190
Total Equity
313
N/A
942
-201%
3 430
N/A
2 791
-19%
Total Liabilities & Equity
341
N/A
669
+96%
3 779
+465%
3 117
-18%
Shares Outstanding
Common Shares Outstanding
376
376
388
408

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.